En esta página
01SPRB precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
SPRB Spruce Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$45,71
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$30,03mínimo 52 semanas
$240,00máximo 52 semanas
Capitalización Bursátil (MRQ)
$126M
P/E
-0.9
BPA
$-50.83
Ingresos
$0
tus insignias
Rango 52S
$30–$240
Calificación del Analista
BUY
Precio Objetivo
$148
P/E
-0.9
ROE
-139.9%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
SPRB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$45.71
Capitalización Bursátil (MRQ)
$126M
P/E
-0.9
BPA
$-50.83
Ingresos
$0
ROE
-139.9%
Deuda/Capital (MRQ)
0.1
Rango 52S
$30–$240
SPRB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 7 de agosto de 2025 | 1-for-75 | Inversa |
| 5 de agosto de 2025 | 1-for-75 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02022-12-31 → 2025-12-31
BPA$-50.832021-12-31 → 2025-12-31
Flujo de caja libre·2020-12-31 → 2024-12-31
Margen neto·2023-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | SPRB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.9promedio 5A ≈-6065.3 | ≈-6065.3 | · | · | |
| P/C (MRQ) | 1.5promedio 5A ≈3944.3 | ≈3944.3 | 1.9 | Infravalorado | |
| EV / EBITDA | -0.4promedio 5A ≈-6378.3 | ≈-6378.3 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -1.9promedio 5A ≈-8405.9 | ≈-8405.9 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.5promedio 5A ≈3944.3 | ≈3944.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | SPRB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -79.3%promedio 5A ≈-54.8% | ≈-54.8% | -68.5% | Débil | |
| ROE | -139.9%promedio 5A ≈-86.1% | ≈-86.1% | -92.0% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | SPRB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.1promedio 5A ≈0.0 | ≈0.0 | 0.0 | Deuda alta | |
| Ratio corriente (MRQ) | 9.2promedio 5A ≈5.9 | ≈5.9 | 6.1 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 4.8promedio 5A ≈5.5 | ≈5.5 | 3.0 | Liquidez sólida | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.1promedio 5A ≈0.0 | ≈0.0 | · | · | |
| Interest Coverage (Cobertura de Intereses) | -405.7promedio 5A ≈-186.2 | ≈-186.2 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | SPRB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -51.3% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | SPRB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.1 | ≈0.1 | 0.0 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-26.2%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-6.68 | $-5.92 | -12.9% |
| 31 de marzo de 2026 | $-8.94 | $-8.99 | 0.58% | |
| 31 de diciembre de 2025 | $-11.28 | $-8.15 | -38.5% | |
| 30 de septiembre de 2025 | $-14.58 | $-14.21 | -2.6% | |
| 30 de junio de 2025 | $-3.50 | $-19.51 | 82.1% | |
| 31 de marzo de 2025 | $-24.00 | $-16.42 | -46.2% | |
| 31 de diciembre de 2024 | $-42.75 | $-16.07 | -166.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $5M | $10M | $0 | |
| R&D Expense | $20M | $46M | $49M | $35M | |
| SG&A Expense | $17M | $15M | $13M | $12M | |
| Operating Expenses | $37M | $61M | $62M | $47M | |
| Operating Income | $-37M | $-56M | $-52M | $-47M | |
| Interest Expense | $90.0K | $307.0K | $483.0K | $420.0K | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-39M | $-53M | $-48M | $-46M | |
| EPS (Basic) | $-50.83 | $-96.40 | $-1.24 | $-1.96 | |
| EPS (Diluted) | $-50.83 | $-96.40 | $-1.24 | $-1.96 | |
| Shares (Basic) | 766,598 | 550,146 | 38,510,220 | 23,527,116 | |
| Shares (Diluted) | 766,598 | 550,146 | 38,510,220 | 23,527,116 | |
| EBITDA | $-37M | $-56M | $-52M | $-47M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $39M | $96M | $24M | |
| Short-term Investments | · | · | $0 | $55M | |
| Receivables | · | · | · | $0 | |
| Prepaid Expense | $353.0K | $3M | $4M | $3M | |
| Other Current Assets | $3M | $2M | $2M | $1M | |
| Current Assets | $52M | $44M | $102M | $84M | |
| Other Non-current Assets | $243.0K | $69.0K | $582.0K | $640.0K | |
| Total Assets | $53M | $45M | $104M | $86M | |
| Accounts Payable | $943.0K | $1M | $3M | $1M | |
| Accrued Liabilities | $9M | $12M | $15M | · | |
| Current Liabilities | $10M | $15M | $24M | $12M | |
| Capital Leases | $419.0K | $736.0K | $1M | $1M | |
| Other Non-current Liabilities | $0 | $282.0K | $236.0K | $161.0K | |
| Total Liabilities | $11M | $16M | $27M | $17M | |
| Long-term Debt | $0 | $2M | $4M | $6M | |
| Total Debt | $0 | $2M | $3M | $5M | |
| Common Stock | $0 | $0 | $4.0K | $3.0K | |
| Retained Earnings | $-289M | $-250M | $-197M | $-149M | |
| AOCI | · | · | $0 | $-558.0K | |
| Stockholders' Equity | $43M | $29M | $77M | $68M | |
| Liabilities + Equity | $53M | $45M | $104M | $86M | |
| Shares Outstanding | 1,372,043 | 563,042 | 547,019 | 23,601,004 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $21.0K | $46.0K | $70.0K | $74.0K | |
| Stock-based Comp | $3M | $5M | $5M | $4M | |
| Operating Cash Flow | $-33M | $-56M | $-33M | $-42M | |
| CapEx | · | $0 | $7.0K | $8.0K | |
| Investing Cash Flow | · | $0 | $56M | $24M | |
| Debt Issued | · | · | · | $0 | |
| Net Debt Issued | $-2M | $-2M | $-2M | $0 | |
| Financing Cash Flow | $43M | $-2M | $49M | $-241.0K | |
| Free Cash Flow | · | $-56M | $-33M | $-42M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | -1143.4% | -515.3% | · | |
| Net Margin | · | -1079.9% | -475.0% | · | |
| EBITDA Margin | · | -1143.4% | -515.3% | · | |
| ROA | -79.3% | -71.1% | -50.5% | -43.5% | |
| ROE | -139.9% | -131.8% | -59.2% | -62.8% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.2 | 2.9 | 4.2 | 6.7 | |
| Quick Ratio | 4.8 | 2.5 | 3.9 | 6.4 | |
| Debt / Equity | 0.0 | 0.1 | 0.0 | 0.1 | |
| LT Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Coverage | -405.7 | -182.9 | -107.6 | -112.6 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $30.99 | $0.68 | $1.86 | $2.90 | |
| Revenue / Share | $0.00 | $0.12 | $0.26 | · | |
| Cash Flow / Share | $-43.47 | $-1.36 | $-0.86 | $-1.77 | |
| Cash / Share | $35.64 | $0.92 | $2.35 | $1.04 | |
| EPS (TTM) | $-50.83 | $-96.40 | $-1.24 | $-1.96 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | · | -51.3% | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $0 | $5M | $10M | $0 | |
| Net Income TTM | $-39M | $-53M | $-48M | $-46M | |
| Market Cap | $120M | $99.77B | $676.22B | $145.63B | |
| Enterprise Value | $71M | $99.73B | $676.13B | $145.56B | |
| P/E | -1.7 | -24.5 | -13291.3 | -3148.3 | |
| P/S | · | 20315.9 | 67025.8 | · | |
| P/B | 2.8 | 3461.8 | 8838.5 | 2126.5 | |
| P / Tangible Book | 2.8 | 3461.8 | 8838.5 | 2126.5 | |
| P / Cash Flow | -3.6 | -1782.8 | -20322.3 | -3493.8 | |
| P / FCF | · | -1782.8 | -20318.0 | -3493.2 | |
| EV / EBITDA | -1.9 | -1776.2 | -13004.2 | -3078.5 | |
| EV / FCF | · | -1782.1 | -20315.2 | -3491.4 | |
| EV / Revenue | · | 20308.4 | 67016.5 | · | |
| Earnings Yield | -58.4% | -4.1% | -0.01% | -0.03% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $697.0K | $602.0K | $2M | $2M | $3M | $3M | $2M | $2M | $0 | $0 | |
| R&D Expense | $12M | $8M | $4M | $5M | $-430.0K | $11M | $21M | $7M | $8M | $10M | $11M | $13M | $13M | $12M | $9M | $9M | |
| SG&A Expense | $4M | $4M | $7M | $3M | $3M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $17M | $12M | $11M | $8M | $3M | $14M | $25M | $10M | $12M | $15M | $14M | $17M | $16M | $15M | $12M | $12M | |
| Operating Income | $-17M | $-12M | $-11M | $-8M | $-3M | $-14M | $-24M | $-9M | $-10M | $-13M | $-11M | $-14M | $-14M | $-13M | $-12M | $-12M | |
| Interest Expense | $1M | $674.0K | $6.0K | $19.0K | $29.0K | $36.0K | $56.0K | $71.0K | $83.0K | $97.0K | $106.0K | $119.0K | $127.0K | $131.0K | $129.0K | $110.0K | |
| Other Non-op | · | · | · | · | · | · | · | $808.0K | $938.0K | $1M | · | $1M | $1M | $539.0K | · | · | |
| Net Income | $-16M | $-12M | $-15M | $-8M | $-2M | $-14M | $-24M | $-9M | $-9M | $-12M | $-10M | $-12M | $-13M | $-13M | $-11M | $-11M | |
| EPS (Basic) | $-6.68 | $-8.94 | $-32.43 | $-14.58 | $-3.50 | $-23.95 | $-63.64 | $-15.75 | $-16.73 | $-0.28 | $-0.22 | $-0.30 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| EPS (Diluted) | $-6.68 | $-8.94 | $-32.43 | $-14.58 | $-3.50 | $-23.95 | $-63.64 | $-15.75 | $-16.73 | $-0.28 | $-0.22 | $-0.30 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| Shares (Basic) | 2,431,075 | 1,372,084 | · | 563,066 | 591,137 | 586,142 | · | 550,645 | 548,789 | 41,096,231 | · | 40,710,692 | 40,547,925 | 31,900,160 | · | 23,560,250 | |
| Shares (Diluted) | 2,431,075 | 1,372,084 | · | 563,066 | 591,137 | 586,142 | · | 550,645 | 548,789 | 41,096,231 | · | 40,710,692 | 40,547,925 | 31,900,160 | · | 23,560,250 | |
| EBITDA | $-17M | $-12M | · | $-8M | $-3M | $-14M | · | · | · | $-13M | · | $-14M | $-14M | $-13M | · | $-12M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $54M | $49M | $11M | $16M | $26M | $39M | $60M | $70M | $81M | $96M | $99M | $97M | $74M | $24M | $22M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $9M | $23M | $45M | $55M | $69M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | · | · | |
| Prepaid Expense | $5M | $864.0K | $353.0K | $932.0K | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Other Current Assets | $234.0K | $88.0K | $3M | $3M | $3M | $2M | $2M | $860.0K | $2M | $2M | $2M | $419.0K | $206.0K | $253.0K | $1M | · | |
| Current Assets | $101M | $55M | $52M | $15M | $21M | $31M | $44M | $64M | $74M | $86M | $102M | $111M | $124M | $137M | $84M | $93M | |
| Other Non-current Assets | $1M | $539.0K | $243.0K | $62.0K | $64.0K | $204.0K | $69.0K | $531.0K | $547.0K | $553.0K | $582.0K | $607.0K | $536.0K | $525.0K | $640.0K | $667.0K | |
| Total Assets | $103M | $56M | $53M | $15M | $22M | $32M | $45M | $65M | $76M | $88M | $104M | $113M | $126M | $139M | $86M | $95M | |
| Accounts Payable | $1M | $3M | $943.0K | $1M | $807.0K | $2M | $1M | $2M | $682.0K | $2M | $3M | $3M | $945.0K | $3M | $1M | $2M | |
| Accrued Liabilities | $7M | $8M | $9M | $8M | $6M | $12M | $12M | $8M | $11M | · | $15M | · | · | · | · | · | |
| Current Liabilities | $11M | $12M | $10M | $9M | $8M | $16M | $15M | $12M | $14M | $18M | $24M | $24M | $23M | $23M | $12M | $12M | |
| Capital Leases | $245.0K | $332.0K | $419.0K | $500.0K | $580.0K | $659.0K | $736.0K | · | · | $950.0K | $1M | · | · | · | $1M | $998.0K | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $282.0K | $273.0K | $262.0K | $250.0K | $236.0K | $220.0K | $202.0K | $181.0K | $161.0K | $139.0K | |
| Total Liabilities | $19M | $22M | $11M | $10M | $9M | $16M | $16M | $13M | $16M | $21M | $27M | $28M | $29M | $31M | $17M | $17M | |
| Long-term Debt | $20M | $20M | $0 | $549.0K | $972.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $5M | $5M | $5M | $6M | |
| Total Debt | $7M | $6M | · | $539.0K | $943.0K | $1M | · | · | · | $3M | · | $4M | $4M | $5M | · | $5M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | |
| Retained Earnings | $-318M | $-302M | $-289M | $-275M | $-266M | $-264M | $-250M | $-227M | $-218M | $-209M | $-197M | $-187M | $-175M | $-162M | $-149M | $-138M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $-3.0K | $-55.0K | $-188.0K | $-558.0K | $-873.0K | |
| Stockholders' Equity | $84M | $35M | $43M | $5M | $13M | $15M | $29M | $52M | $59M | $67M | $77M | $85M | $97M | $108M | $68M | $78M | |
| Liabilities + Equity | $103M | $56M | $53M | $15M | $22M | $32M | $45M | $65M | $76M | $88M | $104M | $113M | $126M | $139M | $86M | $95M | |
| Shares Outstanding | 2,752,810 | 1,372,278 | 1,372,043 | 563,491 | 563,042 | 42,231,285 | 563,042 | 41,302,599 | 41,302,599 | 41,154,799 | 41,029,832 | 40,710,692 | 40,710,692 | 39,746,116 | 23,601,004 | 23,560,250 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $631.0K | $252.0K | $5.0K | $3.0K | $7.0K | $6.0K | $9.0K | $10.0K | $12.0K | $15.0K | $16.0K | $17.0K | $18.0K | $19.0K | $24.0K | $23.0K | |
| Stock-based Comp | $871.0K | $689.0K | $2M | $415.0K | $-77.0K | $544.0K | $961.0K | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $802.0K | $783.0K | |
| Operating Cash Flow | $-22M | $-9M | $-6M | $-5M | $-9M | $-13M | $-21M | $-9M | $-11M | $-15M | $-11M | $-12M | $2M | $-12M | $-12M | $-9M | |
| CapEx | $135.0K | $10.0K | · | · | $0 | $0 | · | · | · | · | $0 | $7.0K | · | · | $0 | $2.0K | |
| Investing Cash Flow | $-135.0K | $-10.0K | · | · | $0 | $0 | · | $0 | $0 | $0 | $9M | $14M | $22M | $10M | $15M | $-17M | |
| Debt Issued | $0 | $14M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $14M | · | · | · | $-405.0K | · | · | · | $-405.0K | · | · | · | $-405.0K | · | · | |
| Financing Cash Flow | $64M | $14M | $45M | $-402.0K | $-400.0K | $-411.0K | $-625.0K | $-405.0K | $-365.0K | $-227.0K | $-552.0K | $-405.0K | $-432.0K | $51M | $36.0K | $-90.0K | |
| Free Cash Flow | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -631.0% | · | -444.4% | -645.4% | -672.1% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | -580.7% | · | -402.0% | -592.3% | -651.3% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -631.0% | · | -444.4% | -645.4% | -672.1% | · | · | |
| ROA | -26.0% | -27.9% | · | -20.4% | -4.2% | -23.6% | · | · | · | -10.3% | · | -11.9% | -11.1% | -10.1% | · | -9.9% | |
| ROE | -33.5% | -49.1% | · | -28.8% | -5.7% | -34.3% | · | · | · | -13.3% | · | -15.1% | -13.8% | -12.3% | · | -11.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 4.7 | · | 1.5 | 2.6 | 2.0 | · | · | · | 4.7 | · | 4.6 | 5.5 | 6.0 | · | 7.8 | |
| Quick Ratio | 8.8 | 4.6 | · | 1.1 | 2.0 | 1.6 | · | · | · | 4.4 | · | 4.5 | 5.3 | 5.8 | · | 7.5 | |
| Debt / Equity | 0.1 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | -15.1 | -17.8 | · | -433.1 | -92.8 | -402.6 | · | · | · | -130.2 | · | -114.8 | -110.0 | -100.8 | · | -105.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $30.42 | $25.25 | · | $9.56 | $23.41 | $0.36 | · | · | · | $1.62 | · | $2.10 | $2.37 | $2.72 | · | $3.33 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | $0.00 | · | · | · | $0.05 | · | $0.08 | $0.05 | $0.06 | · | · | |
| Cash Flow / Share | · | $-6.36 | · | · | · | $-0.29 | · | · | · | $-0.36 | · | · | · | $-0.37 | · | · | |
| Cash / Share | $34.98 | $39.41 | · | $18.93 | $29.10 | $0.61 | · | · | · | $1.97 | · | $2.43 | $2.39 | $1.86 | · | $0.92 | |
| EPS (TTM) | $-62.63 | $-59.45 | · | $-105.67 | $-106.84 | $-120.07 | · | $-32.98 | $-17.53 | $-1.12 | · | $-1.49 | $-1.67 | $-1.86 | · | $-1.88 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $697.0K | $1M | $3M | · | $7M | $10M | $10M | · | $7M | $4M | $2M | · | · | |
| Net Income TTM | $-51M | $-37M | · | $-48M | $-48M | $-55M | · | $-39M | $-43M | $-47M | · | $-49M | $-48M | $-47M | · | $-44M | |
| Market Cap | $149M | $90M | · | $5M | $231M | $68.89B | · | · | · | $181.96B | · | $517.53B | $492.34B | $494.09B | · | $181.56B | |
| Enterprise Value | $59M | $42M | · | $-5M | $216M | $68.87B | · | · | · | $181.88B | · | $517.43B | $492.23B | $493.98B | · | $181.48B | |
| P/E | -0.9 | -1.1 | · | -0.1 | -3.8 | -13.6 | · | -81.0 | -166.2 | -3947.5 | · | -8531.9 | -7241.8 | -6683.5 | · | -4099.1 | |
| P/S | · | · | · | 7.2 | 178.0 | 23681.6 | · | · | · | 17967.4 | · | 71859.9 | 119240.7 | 251575.3 | · | · | |
| P/B | 1.8 | 2.6 | · | 0.9 | 17.5 | 4495.5 | · | · | · | 2731.1 | · | 6061.5 | 5098.8 | 4575.1 | · | 2313.6 | |
| P / Tangible Book | 1.8 | 2.6 | · | 0.9 | 17.5 | 4495.5 | · | 2137.1 | 2033.9 | 2731.1 | · | 6061.5 | 5098.8 | 4575.1 | · | 2313.6 | |
| P / Cash Flow | · | -10.3 | · | · | · | -5412.9 | · | · | · | -12164.4 | · | · | · | -41907.9 | · | · | |
| EV / Revenue | · | · | · | -7.3 | 166.1 | 23673.3 | · | · | · | 17959.7 | · | 71845.4 | 119212.5 | 251517.2 | · | · | |
| Earnings Yield | -116.0% | -91.0% | · | -1180.7% | -26.0% | -7.4% | · | -1.2% | -0.60% | -0.03% | · | -0.01% | -0.01% | -0.01% | · | -0.02% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $5M | $10M | $0 | · |
| Margen Operativo % | · | -1143.4% | -515.3% | · | · |
| Beneficio neto | $-39M | $-53M | $-48M | $-46M | $-42M |
| EPS Diluido | $-50.83 | $-96.40 | $-1.24 | $-1.96 | $-1.81 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 |
| Ratio corriente | 5.2 | 2.9 | 4.2 | 6.7 | 10.4 |
| Ratio Rápido | 4.8 | 2.5 | 3.9 | 6.4 | 10.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-56M | $-33M | $-42M | $-36M |
Propietarios institucionales (13F) 65 declarantes · $109.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
65
Valor en tenencia
$109.9M
Nuevas posiciones
36
Posiciones cerradas
4
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 36 (+24 vs trimestre anterior) | 4 (-5 vs trimestre anterior) | 16 (+10 vs trimestre anterior) | 3 (-2 vs trimestre anterior) | +1.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| AIGH Capital Management LLC | $13 500 000 | 250 000 | 12,29% | Acciones |
| ORBIMED ADVISORS LLC | $10 800 000 | 200 000 | 9,83% | Acciones |
| BlackRock, Inc. | $10 143 144 | 187 836 | 9,23% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $8 692 974 | 160 981 | 7,91% | Acciones |
| Ikarian Capital, LLC | $6 553 224 | 121 356 | 5,96% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 443 874 | 119 331 | 5,86% | Acciones |
| Alyeska Investment Group, L.P. | $4 410 234 | 81 671 | 4,01% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 809 975 | 70 548 | 3,47% | Acciones |
| ADAR1 Capital Management, LLC | $3 656 718 | 67 717 | 3,33% | Acciones |
| Cable Car Capital, LP | $3 240 000 | 60 000 | 2,95% | Acciones |
| CITADEL ADVISORS LLC | $2 802 870 | 51 905 | 2,55% | Acciones |
| STATE STREET CORP | $2 724 300 | 50 450 | 2,48% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 272 320 | 42 080 | 2,07% | Acciones |
| STEMPOINT CAPITAL LP | $2 234 952 | 41 388 | 2,03% | Acciones |
| Eversept Partners, LP | $2 160 000 | 40 000 | 1,97% | Acciones |
| Carlyle Group Inc. | $2 085 493 | 38 620 | 1,90% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 746 792 | 32 348 | 1,59% | Acciones |
| Affinity Asset Advisors, LLC | $1 620 000 | 30 000 | 1,47% | Acciones |
| DIADEMA PARTNERS LP | $1 620 000 | 30 000 | 1,47% | Acciones |
| VANGUARD GROUP INC | $1 556 918 | 17 873 | 1,42% | Acciones |
| Stonepine Capital Management, LLC | $1 554 930 | 28 795 | 1,42% | Acciones |
| Point72 Asset Management, L.P. | $1 527 012 | 28 278 | 1,39% | Acciones |
| Quinn Opportunity Partners LLC | $1 447 740 | 26 810 | 1,32% | Acciones |
| UBS Group AG | $1 262 574 | 23 381 | 1,15% | Acciones |
| ExodusPoint Capital Management, LP | $1 188 000 | 22 000 | 1,08% | Acciones |
| NORTHERN TRUST CORP | $1 138 482 | 21 083 | 1,04% | Acciones |
| Knott David M Jr | $1 080 000 | 20 000 | 0,98% | Acciones |
| Rosalind Advisors, Inc. | $1 080 000 | 20 000 | 0,98% | Acciones |
| AMERIPRISE FINANCIAL INC | $1 017 036 | 18 834 | 0,93% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $998 784 | 18 496 | 0,91% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $991 494 | 18 361 | 0,90% | Acciones |
| Balyasny Asset Management L.P. | $655 452 | 12 138 | 0,60% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $476 650 | 8 813 | 0,43% | Acciones |
| Persistent Asset Partners Ltd | $414 558 | 7 677 | 0,38% | Acciones |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $387 828 | 7 182 | 0,35% | Acciones |
| Bank of New York Mellon Corp | $366 057 | 6 779 | 0,33% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $318 384 | 5 896 | 0,29% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $253 800 | 4 700 | 0,23% | Acciones |
| MORGAN STANLEY | $238 194 | 4 411 | 0,22% | Acciones |
| Pale Fire Capital SE | $206 172 | 3 818 | 0,19% | Acciones |
| RHUMBLINE ADVISERS | $190 026 | 3 519 | 0,17% | Acciones |
| SkyView Investment Advisors, LLC | $162 000 | 3 000 | 0,15% | Acciones |
| DEUTSCHE BANK AG\ | $143 208 | 2 652 | 0,13% | Acciones |
| WELLS FARGO & COMPANY/MN | $125 766 | 2 329 | 0,11% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $102 600 | 1 900 | 0,09% | Acciones |
| CITIGROUP INC | $68 310 | 1 265 | 0,06% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $67 608 | 1 252 | 0,06% | Acciones |
| JPMORGAN CHASE & CO | $62 977 | 1 127 | 0,06% | Acciones |
| Lion Point Capital, LP | $54 000 | 1 000 | 0,05% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $46 656 | 864 | 0,04% | Acciones |
Activistas y propietarios del %+ 5 6 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| HealthCap VIII, L.P., HealthCap VIII GP LLC ×4 presentaciones | 9 de octubre de 2025 | 3,40% | Enmienda | · | SEC |
| RiverVest Venture Fund III, L.P., RiverVest Venture Fund III (Ohio), L.P., RiverVest Venture Partners III (Ohio), LLC, RiverVest Venture Partners III, L.P., RiverVest Venture Partners III, LLC, RiverVest Venture Fund IV, L.P., RiverVest Venture Partners IV, L.P., RiverVest Venture Partners IV, LLC, John P. McKearn, Ph.D., Jay Schmelter, Thomas C. Melzer, Niall O'Donnell, Ph.D. | 10 de enero de 2025 | 4,20% | Enmienda | · | SEC |
| Novo Holdings A/S ×9 presentaciones | 28 de marzo de 2024 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 30 de mayo de 2023 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 23 de octubre de 2020 | · | Presentación inicial | Inversión pasiva | SEC |
| Abingworth LLP, Abingworth Bioventures VII, LP | 16 de octubre de 2020 | · | Presentación inicial | Campaña de la junta directiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 21 insiders · 8 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Javier B. Szwarcberg | CHIEF EXECUTIVE OFFICER | 30 de junio de 2026 A | 19 270 | 0 | 0 | $0 |
| Richard King | Chief Executive Officer | 30 de junio de 2021 J | 2 230 | 0 | 0 | $0 |
| Samir M. Gharib | PRESIDENT AND CFO | 15 de diciembre de 2025 M | 8 263 | 0 | 0 | $0 |
| Adrian W Quartel | Chief Medical Officer | 27 de julio de 2026 A | · | 0 | 0 | $0 |
| Corwin Dale Hooks | Chief Commercial Officer | 9 de marzo de 2026 A | · | 0 | 0 | $0 |
| Kirk Ways | Interim Chief Medical Officer | 11 de diciembre de 2025 D | 1 250 | 0 | 0 | $0 |
| Ralph William Charlton III | CHIEF MEDICAL OFFICER | 16 de diciembre de 2024 M | 161 339 | 0 | 0 | $0 |
| Subaweerage Dias | Chief Medical Officer | 16 de diciembre de 2021 A | · | 0 | 0 | $0 |
| Keli Walbert | Consejero | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Percival Barretto-Ko | Consejero | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Camilla V Simpson | Consejero | 21 de mayo de 2026 A | 0 | 0 | 0 | $0 |
| Bali Muralidhar | Consejero | 22 de julio de 2025 A | 1 792 518 | 0 | 0 | $0 |
| Tiba Aynechi | Consejero | 22 de julio de 2025 A | · | 0 | 0 | $0 |
| Niall O'Donnell, Ph.D. | Consejero | 25 de mayo de 2023 A | 1 326 305 | 0 | 0 | $0 |
| Moghrabi Dina Chaya | Consejero | 25 de mayo de 2022 A | 2 161 022 | 0 | 0 | $0 |
| Jonas Hansson | Consejero | 14 de octubre de 2020 C | 2 033 621 | 0 | 0 | $0 |
| Parkman Healthcare Partners LLC | Propietario del 10% | 6 de octubre de 2025 S | 1 050 | 1 | 2 | $-336 |
| Novo Holdings A/S | Propietario del 10% | 21 de marzo de 2024 S | 2 550 000 | 0 | 0 | $0 |
| Michael G Grey | · | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Daniel K Spiegelman | · | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| HealthCap VIII, L.P. | · | 14 de octubre de 2020 C | 2 033 621 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 15 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,40% | 2 033 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,04% | 9 309 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1 758 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 67 473 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 1 299 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 6 531 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 3 751 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 371 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 681 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 31 892 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 84 935 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 15 701 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 748 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 289 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 17 634 SH | 11 de septiembre de 2026 | Diario |
SPRB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$144.00
+215,0%
5 35,7%
Compra fuerte
8 57,1%
Compra
1 7,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
9 analistas · 2026-09-28Objetivo medio $148.00 +223,8%
← Por Debajo de Todos los Objetivos
Precio Actual $45.71
Mín$104.00
Media$148.00
Máx$230.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| HUMA | · | · | · | · | · | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| VTVT | · | · | · | · | -70.4% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026